FOS and breast carcinoma: To determine whether the difference in reporter GFP expression among the three breast cancer cells is due to the trans-acting factors binding with CR1, chromatin immunoprecipitation (ChIP) assays were performed using antibodies against individual components of AP-1 and NFκB.